5. Mai 2023 – Swissmedic is working on the next digitalisation step and over the next few years will build a digital corporate solution for core processes relating to approvals, authorisation and market surveillance. The aim is to simplify processes, to make data management faster and more targeted, to achieve fewer media discontinuities (i.e. switch of working medium such as manual entry of information previously entered on forms) and, with good user management, to provide more information on regulatory processes. In future, it will be possible to process information more easily with data-centric working. Knowledge of therapeutic products and innovations can thus be made more usable, both inside and outside the organisation.

For more information, see here.